The Gates Foundation Sold All of Its Remaining Microsoft Stock. Should Investors Be Worried?

The Gates Foundation sold its final 7.7 million Microsoft shares, worth about $3.2 billion, as part of its plan to spend down its endowment by 2045 rather than due to a negative view on Microsoft. Microsoft’s latest quarter showed strong fundamentals, with revenue up 18% to $82.9 billion and diluted EPS and net income both rising 23%. The article frames the stock as still attractive for long-term investors despite being down about 13% year to date.

Analysis

The sale itself is not the signal; the signal is that a large, price-insensitive holder is being removed from the overhang at a time when fundamentals are still re-accelerating. That matters because MSFT’s biggest near-term debate is not business quality but whether the stock can keep compounding without multiple compression as expectations remain elevated. A forced philanthropic liquidation also tends to be mechanically absorbed over time, so the market impact is more likely to be a slow, less-visible source of supply than a one-day event.

The more interesting second-order effect is relative positioning across mega-cap AI beneficiaries. If investors treat this as a governance/portfolio-rebalancing event rather than an operating warning, MSFT can still outperform on earnings revisions, but its dominance premium may narrow as capital rotates toward names with more torque to incremental AI spend. That creates a cleaner setup for NVDA on any capex durability confirmation, while leaving INTC structurally less exposed to this specific read-through because the article’s message actually reinforces where the market’s true AI winner-set sits.

The contrarian angle is that the stock may be less expensive than the crowd assumes precisely because narrative risk is now decoupled from fundamentals. If MSFT can keep growing revenue in the high-teens while the foundation sell-down fades into the background, the market could re-rate the name back toward quality-growth leadership over the next 3-6 months. The main risk is not the foundation flow; it is any slowdown in Azure or AI monetization that turns a benign liquidity event into a valuation reset.

Key Decisions for Investors

• Stay long MSFT, but prefer staged entries on 2-4 week weakness rather than chasing strength; the stock’s risk/reward improves if the market keeps confusing donor-driven selling with fundamental concern.
• Express relative value with a long MSFT / short a weaker software proxy or broad tech basket over 1-3 months; the thesis is that fundamentals remain intact while the overhang is temporary, creating a cleaner earnings-quality trade.
• Add to NVDA on pullbacks into the next capex confirmation window; if MSFT’s strength is still translating into enterprise AI spend, NVDA has more operating leverage and should capture the second-order beneficiary trade.
• Avoid shorting MSFT on the foundation sale alone; the better bearish expression would be a call spread hedge if you think AI monetization decelerates over the next 2 quarters, because the flow event by itself is not a durable catalyst.